The new streptoglutarimides A−J (1−10) and the known streptovitacin A (11) were isolated from a marinederived actinomycete, Streptomyces sp. ZZ741. Structures of the isolated compounds were elucidated based on their HRESIMS data, extensive NMR spectroscopic analyses, ECD calculations, Mosher′s method, and a single-crystal X-ray diffraction experiment. Streptoglutarimide H (8) and streptovitacin A (11) showed potent antiproliferative activity against human glioma U87MG and U251 cells with IC 50 values of 1.5−3.8 μM for 8 and 0.05−0.22 μM for 11. All isolated compounds exhibited antimicrobial activity with MIC values of 9−11 μg/mL against methicillin-resistant Staphylococcus aureus, 8−12 μg/mL against Escherichia coli, and 8−20 μg/mL against Candida albicans.
The new alkaloids marinacarbolines
E–Q (1–10, 12–14), caerulomycin N (15), and actinoallonaphthyridine
A (16), together with the known marinacarboline C (11) and cyanogramide (17), were isolated from
the actinomycete Actinoalloteichus sp. ZZ1866. The
structures of the isolated compounds were elucidated based on their
HRESIMS data, extensive NMR spectroscopic analyses, Mosher’s
method, ECD calculations, single-crystal X-ray diffraction analysis,
and chemical degradation studies. Marinacarbolines E–L (1–8) share an indole-pyridone-imidazole
tetracyclic skeleton, which is the first example of this kind of skeleton.
Caerulomycin N (15) and cyanogramide (17) exhibited cytotoxic activity against both human glioma U251 and
U87MG cells with IC50 values of 2.0–7.2 μM.
Marinacarbolines E (1), G (3), I (5), and M (9) showed cytotoxic activity against
U87MG cells with IC50 values of 2.3–8.9 μM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.